Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised crossover phase II study of routine glucarpidase rescue after high-dose methotrexate in bone sarcoma
2006-003203-40Phase 2Terminated
- Sponsor
- University College London
- Start
- Sep 2006
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of glucarpidase in bone cancer (2 arms), sponsored by University College London. Primary endpoint: Primary: fitness for chemotherapy on day 15 of each cycle. Started Sep 2006; status: terminated.
02
Drugs
glucarpidase
03
Conditions
bone cancer
Beyond the preview
Go deeper on 2006-003203-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003203-40.